Search research articles
Contact Us
Filters
Showing results (391-400 of 594) with videos related to
Page
of 60
Sort By:
Nanoscale Horizons
|
April 1, 2020
Electrothermal patches driving the transdermal delivery of insulin
Quentin Pagneux, Ran Ye, Li Chengnan, et al.
Nanoscale Horizons
|
February 20, 2025
Expression of concern: Electrothermal patches driving the transdermal delivery of insulin
Quentin Pagneux, Ran Ye, Li Chengnan, et al.
Chemmedchem
|
October 11, 2012
Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity
Morgan Le Naour, Veronique Leclerc, Amaury Farce, et al.
Circulation Research
|
February 26, 2011
Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways
Giulia Chinetti-Gbaguidi, Morgane Baron, Mohamed Amine Bouhlel, et al.
The Journal of Biological Chemistry
|
February 1, 2006
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
Bertrand Cariou, Kirsten van Harmelen, Daniel Duran-Sandoval, et al.
Heart (British Cardiac Society)
|
June 13, 2022
Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis
Augustin Coisne, David Montaigne, Sandro Ninni, et al.
Circulation Research
|
February 26, 2003
Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism
Andries J Gilde, Karin A J M van der Lee, Peter H M Willemsen, et al.
Journal of the American College of Cardiology
|
May 7, 2013
Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops
David Montaigne, Xavier Marechal, Philippe Lefebvre, et al.
Diabetes
|
January 6, 2017
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
Michael Joubert, Benoît Jagu, David Montaigne, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
January 9, 2014
Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia
Thavarak Ouk, Sophie Gautier, Maud Pétrault, et al.
Page
of 60
Search research articles
Search
Showing results (391-400 of 594) with videos related to
Sort By:
Page
of 60
Nanoscale Horizons
|
April 1, 2020
Electrothermal patches driving the transdermal delivery of insulin
Quentin Pagneux, Ran Ye, Li Chengnan, et al.
Nanoscale Horizons
|
February 20, 2025
Expression of concern: Electrothermal patches driving the transdermal delivery of insulin
Quentin Pagneux, Ran Ye, Li Chengnan, et al.
Chemmedchem
|
October 11, 2012
Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity
Morgan Le Naour, Veronique Leclerc, Amaury Farce, et al.
Circulation Research
|
February 26, 2011
Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways
Giulia Chinetti-Gbaguidi, Morgane Baron, Mohamed Amine Bouhlel, et al.
The Journal of Biological Chemistry
|
February 1, 2006
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
Bertrand Cariou, Kirsten van Harmelen, Daniel Duran-Sandoval, et al.
Heart (British Cardiac Society)
|
June 13, 2022
Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis
Augustin Coisne, David Montaigne, Sandro Ninni, et al.
Circulation Research
|
February 26, 2003
Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism
Andries J Gilde, Karin A J M van der Lee, Peter H M Willemsen, et al.
Journal of the American College of Cardiology
|
May 7, 2013
Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops
David Montaigne, Xavier Marechal, Philippe Lefebvre, et al.
Diabetes
|
January 6, 2017
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
Michael Joubert, Benoît Jagu, David Montaigne, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
January 9, 2014
Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia
Thavarak Ouk, Sophie Gautier, Maud Pétrault, et al.
Page
of 60